These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 28986548)

  • 1. Structure-Activity Relationship Studies of β-Lactam-azide Analogues as Orally Active Antitumor Agents Targeting the Tubulin Colchicine Site.
    Fu DJ; Fu L; Liu YC; Wang JW; Wang YQ; Han BK; Li XR; Zhang C; Li F; Song J; Zhao B; Mao RW; Zhao RH; Zhang SY; Zhang L; Zhang YB; Liu HM
    Sci Rep; 2017 Oct; 7(1):12788. PubMed ID: 28986548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, biological evaluation and cocrystal structures with tubulin of chiral β-lactam bridged combretastatin A-4 analogues as potent antitumor agents.
    Zhou P; Liang Y; Zhang H; Jiang H; Feng K; Xu P; Wang J; Wang X; Ding K; Luo C; Liu M; Wang Y
    Eur J Med Chem; 2018 Jan; 144():817-842. PubMed ID: 29306206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of N-benzylarylamide derivatives as novel tubulin polymerization inhibitors capable of activating the Hippo pathway.
    Song J; Wang SH; Song CH; Zhang WX; Zhu JX; Tian XY; Fu XJ; Xu Y; Jin CY; Zhang SY
    Eur J Med Chem; 2022 Oct; 240():114583. PubMed ID: 35834904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The discovery of novel indazole derivatives as tubulin colchicine site binding agents that displayed potent antitumor activity both in vitro and in vivo.
    Cui YJ; Ma CC; Zhang CM; Tang LQ; Liu ZP
    Eur J Med Chem; 2020 Feb; 187():111968. PubMed ID: 31865012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological evaluation of a novel tubulin inhibitor 7a3 targeting the colchicine binding site.
    Lai Q; Wang Y; Wang R; Lai W; Tang L; Tao Y; Liu Y; Zhang R; Huang L; Xiang H; Zeng S; Gou L; Chen H; Yao Y; Yang J
    Eur J Med Chem; 2018 Aug; 156():162-179. PubMed ID: 30006162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent Antitumor Activities and Structure Basis of the Chiral β-Lactam Bridged Analogue of Combretastatin A-4 Binding to Tubulin.
    Zhou P; Liu Y; Zhou L; Zhu K; Feng K; Zhang H; Liang Y; Jiang H; Luo C; Liu M; Wang Y
    J Med Chem; 2016 Nov; 59(22):10329-10334. PubMed ID: 27805821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and antiproliferative evaluation of novel sulfanilamide-1,2,3-triazole derivatives as tubulin polymerization inhibitors.
    Guo S; Zhen Y; Guo M; Zhang L; Zhou G
    Invest New Drugs; 2018 Dec; 36(6):1147-1157. PubMed ID: 30019099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of novel coumarin-indole derivatives as tubulin polymerization inhibitors with potent anti-gastric cancer activities.
    Song J; Guan YF; Liu WB; Song CH; Tian XY; Zhu T; Fu XJ; Qi YQ; Zhang SY
    Eur J Med Chem; 2022 Aug; 238():114467. PubMed ID: 35605363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, Synthesis, and Biological Evaluation of 1-Methyl-1,4-dihydroindeno[1,2-c]pyrazole Analogues as Potential Anticancer Agents Targeting Tubulin Colchicine Binding Site.
    Liu YN; Wang JJ; Ji YT; Zhao GD; Tang LQ; Zhang CM; Guo XL; Liu ZP
    J Med Chem; 2016 Jun; 59(11):5341-55. PubMed ID: 27172319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-Lactams with antiproliferative and antiapoptotic activity in breast and chemoresistant colon cancer cells.
    Malebari AM; Fayne D; Nathwani SM; O'Connell F; Noorani S; Twamley B; O'Boyle NM; O'Sullivan J; Zisterer DM; Meegan MJ
    Eur J Med Chem; 2020 Mar; 189():112050. PubMed ID: 31954879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects on tubulin polymerization and down-regulation of c-Myc, hTERT and VEGF genes by colchicine haloacetyl and haloaroyl derivatives.
    Marzo-Mas A; Falomir E; Murga J; Carda M; Marco JA
    Eur J Med Chem; 2018 Apr; 150():591-600. PubMed ID: 29550732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel orally active microtubule destabilizing agent S-40 targets the colchicine-binding site and shows potent antitumor activity.
    Du T; Lin S; Ji M; Xue N; Liu Y; Zhang Z; Zhang K; Zhang J; Zhang Y; Wang Q; Sheng L; Li Y; Lu D; Chen X; Xu H
    Cancer Lett; 2020 Dec; 495():22-32. PubMed ID: 32931884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, in vitro, and in vivo anticancer and antiangiogenic activity of novel 3-arylaminobenzofuran derivatives targeting the colchicine site on tubulin.
    Romagnoli R; Baraldi PG; Salvador MK; Prencipe F; Lopez-Cara C; Schiaffino Ortega S; Brancale A; Hamel E; Castagliuolo I; Mitola S; Ronca R; Bortolozzi R; Porcù E; Basso G; Viola G
    J Med Chem; 2015 Apr; 58(7):3209-22. PubMed ID: 25785605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel aromatic amide derivative SY-65 co-targeted tubulin and histone deacetylase 1 with potent anticancer activity in vitro and in vivo.
    Li YR; Liu FF; Liu WB; Zhang YF; Tian XY; Fu XJ; Xu Y; Song J; Zhang SY
    Biochem Pharmacol; 2022 Jul; 201():115070. PubMed ID: 35526597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioactive heterocycles containing a 3,4,5-trimethoxyphenyl fragment exerting potent antiproliferative activity through microtubule destabilization.
    Fu DJ; Yang JJ; Li P; Hou YH; Huang SN; Tippin MA; Pham V; Song L; Zi X; Xue WL; Zhang LR; Zhang SY
    Eur J Med Chem; 2018 Sep; 157():50-61. PubMed ID: 30075402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, biological evaluation and molecular docking studies of aminochalcone derivatives as potential anticancer agents by targeting tubulin colchicine binding site.
    Wang G; Peng Z; Zhang J; Qiu J; Xie Z; Gong Z
    Bioorg Chem; 2018 Aug; 78():332-340. PubMed ID: 29627654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor evaluation of novel phenothiazine derivatives that inhibit migration and tubulin polymerization against gastric cancer MGC-803 cells.
    Liu N; Jin Z; Zhang J; Jin J
    Invest New Drugs; 2019 Feb; 37(1):188-198. PubMed ID: 30345465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and biological evaluation of a series of pyrano chalcone derivatives containing indole moiety as novel anti-tubulin agents.
    Wang G; Li C; He L; Lei K; Wang F; Pu Y; Yang Z; Cao D; Ma L; Chen J; Sang Y; Liang X; Xiang M; Peng A; Wei Y; Chen L
    Bioorg Med Chem; 2014 Apr; 22(7):2060-79. PubMed ID: 24629450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and biological evaluation of millepachine derivatives as a new class of tubulin polymerization inhibitors.
    Wang G; Peng F; Cao D; Yang Z; Han X; Liu J; Wu W; He L; Ma L; Chen J; Sang Y; Xiang M; Peng A; Wei Y; Chen L
    Bioorg Med Chem; 2013 Nov; 21(21):6844-54. PubMed ID: 23993668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New indole-based chalconoids as tubulin-targeting antiproliferative agents.
    Mirzaei H; Shokrzadeh M; Modanloo M; Ziar A; Riazi GH; Emami S
    Bioorg Chem; 2017 Dec; 75():86-98. PubMed ID: 28922629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.